株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

eクリニカルソリューションの世界市場予測 2022年:CDMS、EDC、CTMS、eCOA、分析、RTSM、eTMF、他

eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 249136
出版日 ページ情報 英文 167 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.37円で換算しております。
Back to Top
eクリニカルソリューションの世界市場予測 2022年:CDMS、EDC、CTMS、eCOA、分析、RTSM、eTMF、他 eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022
出版日: 2017年04月19日 ページ情報: 英文 167 Pages
概要

世界のeクリニカルソリューション市場は、2017年〜2022年に12.4%のCAGR (複合年間成長率) で成長し、2022年には76億1000万米ドルの規模に達すると予測されています。市場成長の主な要因として、データ標準化の必要性や、製薬企業やバイオテクノロジー企業での研究開発 (R&D) 投資の拡大、新興国市場での治験活動の活発化などが挙げられます。他方、熟練した専門家の不足や、患者のプライバシー保護への不安感が、市場成長の妨げともなっています。

当レポートは、世界のeクリニカルソリューション市場について調査し、製品、提供形態、治験段階、およびエンドユーザー別による市場の分析、4つの主要地域における市場分析、および主要企業の市場シェア、戦略、製品、流通ネットワーク、製造能力の評価などについて、まとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 主な市場促進因子
      • 治験の運用コスト上昇と規制強化
      • 治験向けソフトウェア・ソリューションの新規導入
      • 治験支援のための政府からの融資・補助金の増額
      • データ標準化の推進のためのeクリニカルソリューションの普及
      • 製薬企業・バイオ医薬品企業の研究開発 (R&D) 投資拡大と、創薬パイプライン関連のIT支出額
      • eクリニカルソリューションの顧客ベースの拡大
    • 主な市場阻害因子
      • eクリニカルソリューションの導入コストの高さ
      • eクリニカルソリューションを運用できる熟練した専門家の不足
      • eクリニカルソリューションの利点に関する、研究者の認識の低さ
    • 主な成長機会
      • アジアの新興国での臨床研究活動の活発化
      • 治験プロセスの外注化:企業内研究部門からCROへ
      • 治験の件数増加 (特に新興国)
      • 手動でのデータ解釈から、治験中でのリアルタイム・データ解析への移行
    • 市場の主な課題
      • 発展途上国でのeクリニカルソリューションの利用制限
      • ソフトウェアの信頼性
      • 患者のプライバシー

第6章 eクリニカルソリューション市場:製品別

  • イントロダクション
  • 電子データ収集 (EDC)・臨床データ管理システム (CDMS)
  • 治験管理システム (CTMS)
  • 臨床分析プラットフォーム
  • ランダム化・治験用品管理 (RTSM)
  • 臨床データ統合プラットフォーム
  • 電子臨床転帰評価 (eCOA) ソリューション
  • 安全性ソリューション
  • 電子治験マスターファイル (eTMF) システム
  • 規制情報管理ソリューション
  • その他のeクリニカルソリューション

第7章 eクリニカルソリューション市場:デリバリー形態別

  • イントロダクション
  • Webホステッド (オンデマンド) ソリューション
  • ライセンス式・企業向け (オンプレミス) ソリューション
  • クラウド型 (SaaS) ソリューション

第8章 eクリニカルソリューション市場:治験段階別

  • イントロダクション
  • 第I相
  • 第II相
  • 第III相
  • 第IV相

第9章 eクリニカルソリューション市場:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオ医薬品企業
  • 医薬品開発業務受託機関 (CRO)
  • コンサルティングサービス企業
  • 医療機器メーカー
  • 病院
  • 教育・研究機関

第10章 eクリニカルソリューション市場:地域別

  • イントロダクション
  • 北米 (米国、カナダ)
  • 欧州
  • アジア太平洋地域
  • その他

第11章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合状況・動向
    • 協定、事業提携、事業協力
    • 製品導入
    • 製品発売・改良
    • 企業合併・買収 (M&A)
    • 事業拡張
    • その他の戦略

第12章 企業プロファイル

  • イントロダクション
  • ORACLE CORPORATION
  • MEDIDATA SOLUTIONS, INC.
  • PAREXEL INTERNATIONAL CORPORATION
  • BIOCLINICA, INC. (A SUBSIDIARY OF CINVEN)
  • DATATRAK INTERNATIONAL, INC.
  • CRF HEALTH
  • ERT CLINICAL
  • MERGE HEALTHCARE INCORPORATED
  • OMNICOMM SYSTEMS, INC.
  • MAXISIT INC.
  • BIO-OPTRONICS, INC.
  • ECLINICAL SOLUTIONS, LLC.

第13章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HIT 2208

The global eClinical solutions market is estimated to reach 7.61 billionby 2022, at a high CAGR of 12.4% in the forecast period (2017-2022). The growth of the global eClinical solutions market is driven by factors such as a need for improved data standardization and an increase in R&D expenditure by pharma-biotech companies with significant IT budgets for drug development. In addition, the rising number of clinical trials, especially across emerging countries in the Asia-Pacific region, offers growth opportunities for vendors of eClinical solutions. However, a dearth of skilled research professionals and concerns over patient data privacy are hampering the adoption of these solutions.

On the basis of clinical trial phases, the global eClinical solutions market is divided into phase I, phase II, phase III, and phase IV. The phase III clinical trials segment accounted for the largest share of the global eClinical solutions market in 2016. In addition, the phase III clinical trials segment is expected to grow at the highest CAGR during the forecast period.

Geographically, North America commanded the largest share of the global eClinical solutions market in 2016, followed by Europe. The large market share of North America is attributed to the significant number of ongoing clinical trials in this region. A number of factors such as the increasing government grants to support clinical trials, continuous product development and launch by eClinical solution vendors, growth in the number of partnerships for new drug development, high prevalence of lifestyle diseases, and an increasing aging population are further stimulating the demand for eClinical solutions in North America. However, strict and lengthy government requirements and high cost of conducting trials are negatively affecting the growth of the market in this region.

Although developed regions such as North America and Europe held large shares in the eClinical solutions market in 2016, it is the Asia-Pacific region that is poised to achieve the highest CAGR in the next five years. Factors such as the increasing outsourcing of clinical trial studies by large pharma and biopharma companies to Asia-Pacific countries, the presence of large patient population, and the low operating cost of conducting clinical trials are propelling the growth of the eClinical solutions market in this region.

The eClinical solutions market is highly competitive, with a large number of global and local players. Oracle Corporation (U.S.) Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) were the top three players in the eClinical solutions market in 2016. Partnerships, agreements, and collaborations; product launches, enhancements, and deployments; mergers and acquisitions; and geographic expansions are the major strategies adopted by most players to achieve growth in the eClinical solutions market.

Research Coverage:

The report covers software solutions used across all phases in the clinical trial process. It aims at estimating the market size and future growth potential of this market across different segments such as product type, delivery mode, clinical trial phase, end user, and regions. The report also includes an in-depth competitive analysis of the key players with their company profiles, recent developments, and key market strategies.

Reasons to Buy the Report:

This report focuses on various levels of analysis-market share analysis of the top players and company profiles, which discuss basic views on the competitive landscape; emerging and high-growth segments of the eClinical solutions market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help them garner greater market shares. Companies purchasing the report could use any one of the combination of the strategies mentioned below, namely, market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on eClinical solutions offered by the top 10 players in the market. The report analyzes the eClinical solutions market, by product, delivery mode, clinical trial phase, and end users across four geographies.
  • Product Development/Innovation: Detailed insights on current technologies, research and development activities, and product launches in the eClinical solutions market.
  • Market Development: Comprehensive information of lucrative emerging markets. The report analyzes the markets for various eClinical solutions across four geographies (North America, Europe, Asia-Pacific, and the Rest of the World).
  • Competitive Assessment: Assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the eClinical solutions market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MAJOR MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Breakdown of primaries
      • 2.1.2.2. Key data from primary sources
      • 2.1.2.3. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
      • 2.2.1.1. Bottom-up approach
      • 2.2.1.2. Top-down approach
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ECLINICAL SOLUTIONS: MARKET OVERVIEW
  • 4.2. ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2015KKKKK VS. 2015KKKKK VS. 2022KKKKK (USD MILLION)
  • 4.3. REGIONAL ANALYSIS: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE (2016)
  • 4.4. ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE (2017KKKKK VS. 2022)
  • 4.5. REGIONAL ANALYSIS: ECLINICAL SOLUTIONS MARKET, BY END USER (2017-2022)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MAJOR MARKET DRIVERS
      • 5.2.1.1. Increasing operational costs and regulatory requirements associated with clinical research studies
      • 5.2.1.2. Growing adoption of novel software solutions in clinical research
      • 5.2.1.3. Rising government funding & grants to support clinical trials
      • 5.2.1.4. Growing adoption of eClinical solutions for improved data standardization
      • 5.2.1.5. Increasing R&D expenditure by pharma-biotech companies with augmented IT expenditure allocations for drug development pipeline
      • 5.2.1.6. Growing customer base for eClinical solutions
    • 5.2.2. MAJOR MARKET RESTRAINTS
      • 5.2.2.1. High implementation costs associated with eClinical solutions
      • 5.2.2.2. Dearth of skilled professionals for operating eClinical solutions
      • 5.2.2.3. Limited awareness among researchers related to advantages of eClinical solutions
    • 5.2.3. KEY GROWTH OPPORTUNITIES
      • 5.2.3.1. Increasing clinical research activities in emerging Asian countries
      • 5.2.3.2. Increased outsourcing of clinical trial processes by industrial researchers to CROs
      • 5.2.3.3. Rising number of clinical trials, especially across emerging countries
      • 5.2.3.4. Shift from manual data interpretation to real-time data analysis during clinical studies
    • 5.2.4. MAJOR MARKET CHALLENGES
      • 5.2.4.1. Limited adoption of eClinical solutions in developing nations
      • 5.2.4.2. Software reliability
      • 5.2.4.3. Patient privacy

6. GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS
  • 6.3. CLINICAL TRIAL MANAGEMENT SYSTEMS
  • 6.4. CLINICAL ANALYTICS PLATFORMS
  • 6.5. RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT
  • 6.6. CLINICAL DATA INTEGRATION PLATFORMS
  • 6.7. ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS
  • 6.8. SAFETY SOLUTIONS
  • 6.9. ELECTRONIC TRIAL MASTER FILE SYSTEMS
  • 6.10. REGULATORY INFORMATION MANAGEMENT SOLUTIONS
  • 6.11. OTHER ECLINICAL SOLUTIONS

7. ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE

  • 7.1. INTRODUCTION
  • 7.2. WEB-HOSTED (ON-DEMAND) SOLUTIONS
  • 7.3. LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS
  • 7.4. CLOUD-BASED (SAAS) SOLUTIONS

8. GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE

  • 8.1. INTRODUCTION
  • 8.2. PHASE I CLINICAL TRIALS
  • 8.3. PHASE II CLINICAL TRIALS
  • 8.4. PHASE III CLINICAL TRIALS
  • 8.5. PHASE IV CLINICAL TRIALS

9. ECLINICAL SOLUTIONS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 9.3. CONTRACT RESEARCH ORGANIZATIONS
  • 9.4. CONSULTING SERVICE COMPANIES
  • 9.5. MEDICAL DEVICE MANUFACTURERS
  • 9.6. HOSPITALS
  • 9.7. ACADEMIC RESEARCH INSTITUTES

10. ECLINICAL SOLUTIONS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
  • 10.4. ASIA-PACIFIC
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 11.3.2. PRODUCT DEPLOYMENTS
    • 11.3.3. PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS
    • 11.3.4. MERGERS & ACQUISITIONS
    • 11.3.5. EXPANSIONS
    • 11.3.6. OTHER STRATEGIES

12. COMPANY PROFILES

  • 12.1. INTRODUCTION

(OVERVIEW, PRODUCTS AND SERVICES, FINANCIALS, STRATEGY & DEVELOPMENT)*

  • 12.2. ORACLE CORPORATION
  • 12.3. MEDIDATA SOLUTIONS, INC.
  • 12.4. PAREXEL INTERNATIONAL CORPORATION
  • 12.5. BIOCLINICA, INC. (A SUBSIDIARY OF CINVEN)
  • 12.6. DATATRAK INTERNATIONAL, INC.
  • 12.7. CRF HEALTH
  • 12.8. ERT CLINICAL
  • 12.9. MERGE HEALTHCARE INCORPORATED
  • 12.10. OMNICOMM SYSTEMS, INC.
  • 12.11. MAXISIT INC.
  • 12.12. BIO-OPTRONICS, INC.
  • 12.13. ECLINICAL SOLUTIONS, LLC.

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: U.S.: INDICATIVE LIST OF LIFE SCIENCE STARTUPS LAUNCHED BETWEEN 2011 & 2015
  • TABLE 2: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 3: GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 5: GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 7: GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 9: GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 11: GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 15: GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 17: GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 19: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE ,BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2015-2022 (USD MILLION)
  • TABLE 24: WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 28: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 32: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 37: ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 38: KEY STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES (2011-2015)
  • TABLE 39: ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 40: ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 42: ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 43: ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 44: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 45: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 46: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 47: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 49: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 50: U.S.: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 51: U.S.: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 52: CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 53: CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 54: EMA-APPROVED BIOSIMILARS
  • TABLE 55: EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 56: EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 57: EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 58: EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 62: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 63: ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 64: ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION)
  • TABLE 65: ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION)
  • TABLE 66: ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 67: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2013-2017)
  • TABLE 68: PRODUCT DEPLOYMENTS (2013-2017)
  • TABLE 69: PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS (2013-2017)
  • TABLE 70: MERGERS & ACQUISITIONS (2013-2017)
  • TABLE 71: EXPANSIONS (2013-2017)
  • TABLE 72: OTHER STRATEGIES (2013-2017)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: ECLINICAL SOLUTIONS MARKET: END-USER ANALYSIS APPROACH
  • FIGURE 4: ECLINICAL SOLUTIONS MARKET: BOTTOM-UP APPROACH
  • FIGURE 5: ECLINICAL SOLUTIONS MARKET: TOP-DOWN APPROACH
  • FIGURE 6: ECLINICAL SOLUTIONS MARKET: DATA TRIANGULATION
  • FIGURE 7: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION)
  • FIGURE 8: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 9: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 11: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2016 (USD MILLION)
  • FIGURE 12: EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
  • FIGURE 13: EDC & CDMS SEGMENT TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2022
  • FIGURE 14: WEB-HOSTED DELIVERY MODE DOMINATED THE ECLINICAL SOLUTIONS MARKET ACROSS ALL REGIONAL SEGMENTS IN 2016
  • FIGURE 15: PHASE III CLINICAL TRIALS TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: CONTRACT RESEARCH ORGANIZATIONS SEGMENT IN ASIA-PACIFIC IS EXPECTED TO WITNESS THE HIGHEST GROWTH RATE
  • FIGURE 17: GLOBAL ECLINICAL SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: EDC AND CDMS SEGMENT DOMINATED THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2016
  • FIGURE 19: NORTH AMERICA IS ESTIMATED TO BE THE LARGEST GEOGRAPHIC SEGMENT FOR EDC AND CDMS SOLUTIONS MARKET IN 2017
  • FIGURE 20: ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING GEOGRAPHIC SEGMENT FOR CTMS MARKET DURING 2017-2022
  • FIGURE 21: NORTH AMERICA IS ESTIMATED TO BE THE LARGEST GEOGRAPHIC SEGMENT FOR CLINICAL ANALYTICS PLATFORMS MARKET IN 2017
  • FIGURE 22: ASIA-PACIFIC IS PROJECTED TO BE THE FASTEST-GROWING GEOGRAPHIC SEGMENT FOR RTSM SOLUTIONS MARKET TILL 2022
  • FIGURE 23: WEB-HOSTED SOLUTIONS TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2016
  • FIGURE 24: PHASE III TRIALS TO WITNESS HIGHEST DEMAND GROWTH FOR ECLINICAL SOLUTIONS DURING THE FORECAST PERIOD
  • FIGURE 25: GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER (2016)
  • FIGURE 26: R&D EXPENDITURE OF TOP 8 PHARMACEUTICAL COMPANIES, 2013 VS. 2015 (USD MILLION)
  • FIGURE 27: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 28: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SNAPSHOT
  • FIGURE 29: EUROPE: ECLINICAL SOLUTIONS MARKET SNAPSHOT
  • FIGURE 30: EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY (2012)
  • FIGURE 31: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SNAPSHOT
  • FIGURE 32: ROW: ECLINICAL SOLUTIONS MARKET SNAPSHOT
  • FIGURE 33: GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 34: GEOGRAPHIC REVENUE MIX OF THE LEADING MARKET PLAYERS (2015)*
  • FIGURE 35: ORACLE CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 36: MEDIDATA SOLUTIONS, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 37: PAREXEL INTERNATIONAL CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 38: DATATRAK INTERNATIONAL, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 39: MERGE HEALTHCARE INCORPORATED: COMPANY SNAPSHOT (2014)
  • FIGURE 40: OMNICOMM SYSTEMS, INC.: COMPANY SNAPSHOT (2015)
Back to Top